Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|February 19, 2008
Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United KingdomThomas M MacDonald, Steven V Morant
BJU International|March 24, 2007
Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UKPhilip D Kell, Kyle Hvidsten, Steven V Morant, et al.
British Journal of Clinical Pharmacology|October 14, 2016
Spironolactone use and risk of incident cancers: a retrospective, matched cohort studyIsla S Mackenzie, Steven V Morant, Li Wei, et al.
British Journal of Clinical Pharmacology|December 14, 2019
A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactoneCharlotte E Mills, Virginia Govoni, Luca Faconti, et al.
British Journal of Clinical Pharmacology|July 16, 2020
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysisDaniel R Morales, Steven V Morant, Thomas M MacDonald, et al.
Pageof 1